157
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Evaluation of the Sociodemographic, Behavioral and Clinical Influences on Complete Antiretroviral Therapy Adherence Among HIV-Infected Adults Receiving Medical Care in Houston, Texas

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 539-555 | Published online: 18 May 2021

References

  • Moreno S, Lopez Aldeguer J, Arribas JR, et al. The future of antiretroviral therapy: challenges and needs. J Antimicrob Chemother. 2010;65(5):827–835. doi:10.1093/jac/dkq061
  • Este JA, Cihlar T. Current status and challenges of antiretroviral research and therapy. Antiviral Res. 2010;85(1):25–33. doi:10.1016/j.antiviral.2009.10.007
  • Palmisano L, Vella S. A brief history of antiretroviral therapy of HIV infection: success and challenges. Ann Ist Super Sanita. 2011;47(1):44–48. doi:10.4415/ANN_11_01_10
  • Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. Lancet. 2013;382(9903):1525–1533. doi:10.1016/S0140-6736(13)61809-7
  • De Cock KM, Jaffe HW, Curran JW. The evolving epidemiology of HIV/AIDS. Aids. 2012;26(10):1205–1213. doi:10.1097/QAD.0b013e328354622a
  • Stricker SM, Fox KA, Baggaley R, et al. Retention in care and adherence to ART are critical elements of HIV care interventions. AIDS Behav. 2014;18(Suppl 5):S465–75. doi:10.1007/s10461-013-0598-6
  • Castel AD, Magnus M, Greenberg AE. Update on the epidemiology and prevention of HIV/AIDS in the United States. Curr Epidemiol Rep. 2015;2(2):110–119. doi:10.1007/s40471-015-0042-8
  • Mannheimer S, Hirsch-Moverman Y. What we know and what we do not know about factors associated with and interventions to promote antiretroviral adherence. Curr Infect Dis Rep. 2015;17(4):466. doi:10.1007/s11908-015-0466-9
  • Mannheimer SB, Matts J, Telzak E, et al. Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence. AIDS Care. 2005;17(1):10–22. doi:10.1080/09540120412331305098
  • Ortego C, Huedo-Medina TB, Llorca J, et al. Adherence to highly active antiretroviral therapy (HAART): a meta-analysis. AIDS Behav. 2011;15(7):1381–1396. doi:10.1007/s10461-011-9942-x
  • Al-Dakkak I, Patel S, McCann E, Gadkari A, Prajapati G, Maiese EM. The impact of specific HIV treatment-related adverse events on adherence to antiretroviral therapy: a systematic review and meta-analysis. AIDS Care. 2013;25(4):400–414. doi:10.1080/09540121.2012.712667
  • Mocroft A, Youle M, Moore A, et al. Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre. Aids. 2001;15(2):185–194. doi:10.1097/00002030-200101260-00007
  • Beer L, Heffelfinger J, Frazier E, et al. Use of and adherence to antiretroviral therapy in a large U.S. sample of HIV-infected adults in care, 2007–2008. Open AIDS J. 2012;6:213–223. doi:10.2174/1874613601206010213
  • Schaecher KL. The importance of treatment adherence in HIV. Am J Manag Care. 2013;19(12 Suppl):S231–7.
  • Glass T, Cavassini M. Asking about adherence - from flipping the coin to strong evidence. Swiss Med Wkly. 2014;144:w14016. doi:10.4414/smw.2014.14016
  • Cooke CE, Lee HY, Xing S. Adherence to antiretroviral therapy in managed care members in the United States: a retrospective claims analysis. J Manag Care Pharm. 2014;20(1):86–92. doi:10.18553/jmcp.2014.20.1.86
  • Genberg BL, Lee Y, Rogers WH, Wilson IB. Four types of barriers to adherence of antiretroviral therapy are associated with decreased adherence over time. AIDS Behav. 2015;19(1):85–92. doi:10.1007/s10461-014-0775-2
  • Burgess MJ, Zeuli JD, Kasten MJ. Management of HIV/AIDS in older patients-drug/drug interactions and adherence to antiretroviral therapy. HIV AIDS. 2015;7:251–264. doi:10.2147/HIV.S39655
  • Ghidei L, Simone MJ, Salow MJ, et al. Aging, antiretrovirals, and adherence: a meta-analysis of adherence among older HIV-infected individuals. Drugs Aging. 2013;30(10):809–819. doi:10.1007/s40266-013-0107-7
  • Wutoh AK, Brown CM, Kumoji EK, et al. Antiretroviral adherence and use of alternative therapies among older HIV-infected adults. J Natl Med Assoc. 2001;93(7–8):243–250.
  • Sankar A, Nevedal A, Neufeld S, Berry R, Luborsky M. What do we know about older adults and HIV? A review of social and behavioral literature. AIDS Care. 2011;23(10):1187–1207. doi:10.1080/09540121.2011.564115
  • Iachan R, Johnson CH, Harding RL, et al. Design and weighting methods for a nationally representative sample of HIV-infected adults receiving medical care in the United States-Medical Monitoring Project. Open AIDS J. 2016;10:164–181. doi:10.2174/1874613601610010164
  • Weiser J, Beer L, Frazier EL, et al. Service delivery and patient outcomes in Ryan White HIV/AIDS program-funded and -nonfunded health care facilities in the United States. JAMA Intern Med. 2015;175(10):1650–1659. doi:10.1001/jamainternmed.2015.4095
  • Reynolds NR, Sun J, Nagaraja HN, Gifford AL, Wu AW, Chesney MA. Optimizing measurement of self-reported adherence with the ACTG adherence questionnaire: a cross-protocol analysis. J Acquir Immune Defic Syndr. 2007;46(4):402–409. doi:10.1097/QAI.0b013e318158a44f
  • Langebeek N, Gisolf EH, Reiss P, et al. Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: a meta-analysis. BMC Med. 2014;12:142. doi:10.1186/s12916-014-0142-1
  • Thompson-Paul AM, Wei SC, Mattson CL, et al. Obesity among HIV-infected adults receiving medical care in the United States: data from the cross-sectional Medical Monitoring Project and National Health and Nutrition Examination Survey. Medicine. 2015;94(27):e1081. doi:10.1097/MD.0000000000001081
  • Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613. doi:10.1046/j.1525-1497.2001.016009606.x
  • Uthman OA, Oladimeji O, Nduka C. Adherence to antiretroviral therapy among HIV-infected prisoners: a systematic review and meta-analysis. AIDS Care. 2017;29(4):489–497. doi:10.1080/09540121.2016.1223799
  • Westergaard RP, Spaulding AC, Flanigan TP. HIV among persons incarcerated in the US: a review of evolving concepts in testing, treatment and linkage to community care. Curr Opin Infect Dis. 2013;26(1):10–16. doi:10.1097/QCO.0b013e32835c1dd0
  • Aberg JA, Gallant JE, Ghanem KG, Emmanuel P, Zingman BS, Horberg MA. Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2014;58(1):1–10. doi:10.1093/cid/cit757
  • Beer L, Skarbinski J. Adherence to antiretroviral therapy among HIV-infected adults in the United States. AIDS Educ Prev. 2014;26(6):521–537. doi:10.1521/aeap.2014.26.6.521
  • Frankel MR, McNaghten A, Shapiro MF, et al. A probability sample for monitoring the HIV-infected population in care in the U.S. and in selected states. Open AIDS J. 2012;6:67–76. doi:10.2174/1874613601206010067
  • Mgbere O, Khuwaja S, Bell TK, et al. System and patient barriers to care among people living with HIV/AIDS in Houston/Harris County, Texas: HIV medical care providers’ perspectives. J Int Assoc Provid AIDS Care. 2015;14(6):505–515. doi:10.1177/2325957414539045
  • Nokes K, Johnson MO, Webel A, et al. Focus on increasing treatment self-efficacy to improve human immunodeficiency virus treatment adherence. J Nurs Scholarsh. 2012;44(4):403–410. doi:10.1111/j.1547-5069.2012.01476.x
  • Centers for Disease Control and Prevention. Behavioral and clinical characteristics of persons receiving medical care for HIV infection—Medical Monitoring Project, United States, 2014 cycle (June 2014–May 2015); 2020. Available from: https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-hssr-mmp-2014.pdf. Accessed March 19, 2020.
  • Burnham KP, Anderson DR. P values are only an index to evidence: 20th- vs. 21st-century statistical science. Ecology. 2014;95(3):627–630. doi:10.1890/13-1066.1
  • Vrieze SI. Model selection and psychological theory: a discussion of the differences between the Akaike information criterion (AIC) and the Bayesian information criterion (BIC). Psychol Methods. 2012;17(2):228–243. doi:10.1037/a0027127
  • Maartens G, Celum C, Lewin SR. HIV infection: epidemiology, pathogenesis, treatment, and prevention. Lancet. 2014;384(9939):258–271. doi:10.1016/S0140-6736(14)60164-1
  • Scott Sutton S, Magagnoli J, Hardin JW. Impact of pill burden on adherence, risk of hospitalization, and viral suppression in patients with HIV infection and AIDS receiving antiretroviral therapy. Pharmacotherapy. 2016;36(4):385–401. doi:10.1002/phar.1728
  • Saberi P, Neilands TB, Vittinghoff E, Johnson MO, Chesney M, Cohn SE. Barriers to antiretroviral therapy adherence and plasma HIV RNA suppression among AIDS clinical trials group study participants. AIDS Patient Care STDS. 2015;29(3):111–116. doi:10.1089/apc.2014.0255
  • Nachega JB, Parienti JJ, Uthman OA, et al. Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: a meta-analysis of randomized controlled trials. Clin Infect Dis. 2014;58(9):1297–1307. doi:10.1093/cid/ciu046
  • Manzano-García M, Pérez-Guerrero C, Álvarez de Sotomayor Paz M, Robustillo-Cortés MLA, Almeida-González CV, Morillo-Verdugo R. Identification of the medication regimen complexity index as an associated factor of nonadherence to antiretroviral treatment in HIV positive patients. Ann Pharmacother. 2018;52(9):862–867. doi:10.1177/1060028018766908
  • Altice F, Evuarherhe O, Shina S, Carter G, Beaubrun AC. Adherence to HIV treatment regimens: systematic literature review and meta-analysis. Patient Prefer Adherence. 2019;13:475–490. doi:10.2147/PPA.S192735
  • Moreno S, Perno CF, Mallon PW, et al. Two-drug vs. three-drug combinations for HIV-1: do we have enough data to make the switch? HIV Med. 2019;20(Suppl 4):2–12. doi:10.1111/hiv.12716
  • Cantudo-Cuenca MR, Jiménez-Galán R, Almeida-Gonzalez CV, Morillo-Verdugo R. Concurrent use of comedications reduces adherence to antiretroviral therapy among HIV-infected patients. J Manag Care Spec Pharm. 2014;20(8):844–850. doi:10.18553/jmcp.2014.20.8.844
  • Borrego Y, Gómez-Fernández E, Jiménez R, Cantudo R, Almeida-González CV, Morillo R. Predictors of primary non-adherence to concomitant chronic treatment in HIV-infected patients with antiretroviral therapy. Eur J Hosp Pharm. 2018;25(3):127–131. doi:10.1136/ejhpharm-2016-001000
  • Cordova E, Cecchini D, Rodriguez C. Potential drug-drug interactions in HIV-perinatally infected adolescents on antiretroviral therapy in Buenos Aires, Argentina. J Int AIDS Soc. 2014;17(Suppl 4):19764. doi:10.7448/IAS.17.4.19764
  • Gimeno-Gracia M, Crusells-Canales MJ, Javier Armesto-Gómez F, Rabanaque-Hernández MJ. Prevalence of concomitant medications in older HIV+ patients and comparison with general population. HIV Clin Trials. 2015;16(3):117–124. doi:10.1179/1528433614Z.0000000012
  • Costa JM, Torres TS, Coelho LE, Luz PM. Adherence to antiretroviral therapy for HIV/AIDS in Latin America and the Caribbean: systematic review and meta-analysis. J Int AIDS Soc. 2018;21(1):e25066. doi:10.1002/jia2.25066
  • Mills EJ, Nachega JB, Buchan I, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006;296(6):679–690. doi:10.1001/jama.296.6.679
  • Morowatisharifabad MA, Movahed E, Nikooie R, et al. Adherence to medication and physical activity among people living with HIV/AIDS. Iran J Nurs Midwifery Res. 2019;24(5):397–399. doi:10.4103/ijnmr.IJNMR_205_18
  • Shubber Z, Mills EJ, Nachega JB, et al. Patient-reported barriers to adherence to antiretroviral therapy: a systematic review and meta-analysis. PLoS Med. 2016;13(11):e1002183. doi:10.1371/journal.pmed.1002183
  • Ferrand RA, Briggs D, Ferguson J, et al. Viral suppression in adolescents on antiretroviral treatment: review of the literature and critical appraisal of methodological challenges. Trop Med Int Health. 2016;21(3):325–333. doi:10.1111/tmi.12656
  • Soares RCA, Brito AM, Lima K, Lapa TM. Adherence to antiretroviral therapy among people living with HIV/AIDS in northeastern Brazil: a cross-sectional study. Sao Paulo Med J. 2019;137(6):479–485. doi:10.1590/1516-3180.2019.0212170919
  • Shaw S, Amico KR. Antiretroviral therapy adherence enhancing interventions for adolescents and young adults 13–24 years of age: a review of the evidence base. J Acquir Immune Defic Syndr. 2016;72(4):387–399. doi:10.1097/QAI.0000000000000977
  • Zanoni BC, Mayer KH. The adolescent and young adult HIV cascade of care in the United States: exaggerated health disparities. AIDS Patient Care STDS. 2014;28(3):128–135. doi:10.1089/apc.2013.0345
  • Thompson MA, Mugavero MJ, Amico KR, et al. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS care panel. Ann Intern Med. 2012;156(11):817–833. doi:10.7326/0003-4819-156-11-201206050-00419
  • Krentz HB, Gill MJ. Increased costs of HIV care associated with aging in an HIV-infected population. HIV Med. 2015;16(1):38–47. doi:10.1111/hiv.12176
  • Chambers LA, Wilson MG, Rueda S, Gogolishvili D, Shi MQ, Rourke SB. Evidence informing the intersection of HIV, aging and health: a scoping review. AIDS Behav. 2014;18(4):661–675. doi:10.1007/s10461-013-0627-5
  • Knobel H, Urbina O, González A, et al. Impact of different patterns of nonadherence on the outcome of highly active antiretroviral therapy in patients with long-term follow-up. HIV Med. 2009;10(6):364–369. doi:10.1111/j.1468-1293.2009.00696.x
  • Kalichman S, Kalichman MO, Cherry C. Medication beliefs and structural barriers to treatment adherence among people living with HIV infection. Psychol Health. 2016;31(4):383–395. doi:10.1080/08870446.2015.1111371
  • Culbert GJ. Violence and the perceived risks of taking antiretroviral therapy in US jails and prisons. Int J Prison Health. 2014;10(2):94–110. doi:10.1108/IJPH-05-2013-0020
  • Belayihun B, Negus R. Antiretroviral treatment adherence rate and associated factors among people living with HIV in Dubti Hospital, Afar Regional State, East Ethiopia. Int Scholarly Res Notices. 2015;2015:5. doi:10.1155/2015/187360
  • Sin NL, DiMatteo MR. Depression treatment enhances adherence to antiretroviral therapy: a meta-analysis. Ann Behav Med. 2014;47(3):259–269. doi:10.1007/s12160-013-9559-6
  • Nilsson Schonnesson L, Williams ML, Ross MW, Bratt G, Keel B. Factors associated with suboptimal antiretroviral therapy adherence to dose, schedule, and dietary instructions. AIDS Behav. 2007;11(2):175–183. doi:10.1007/s10461-006-9160-0
  • Haberer JE, Bwana BM, Orrell C, et al. ART adherence and viral suppression are high among most non-pregnant individuals with early-stage, asymptomatic HIV infection: an observational study from Uganda and South Africa. J Int AIDS Soc. 2019;22(2):e25232. doi:10.1002/jia2.25232
  • Ayieko J, Brown L, Anthierens S, et al. “Hurdles on the path to 90-90-90 and beyond”: qualitative analysis of barriers to engagement in HIV care among individuals in rural East Africa in the context of test-and-treat. PLoS One. 2018;13(8):e0202990. doi:10.1371/journal.pone.0202990
  • Katz IT, Ryu AE, Onuegbu AG, et al. Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis. J Int AIDS Soc. 2013;16(Suppl 3):18640. doi:10.7448/IAS.16.3.18640
  • Chesney MA. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis. 2000;30(Suppl 2):S171–S176. doi:10.1086/313849
  • Atkinson MJ, Petrozzino JJ. An evidence-based review of treatment-related determinants of patients’ nonadherence to HIV medications. AIDS Patient Care STDS. 2009;23(11):903–914. doi:10.1089/apc.2009.0024
  • Hansana V, Sanchaisuriya P, Durham J, et al. Adherence to antiretroviral therapy (ART) among people living with HIV (PLHIV): a cross-sectional survey to measure in Lao PDR. BMC Public Health. 2013;13:617. doi:10.1186/1471-2458-13-617
  • Damulira C, Mukasa MN, Byansi W, et al. Examining the relationship of social support and family cohesion on ART adherence among HIV-positive adolescents in southern Uganda: baseline findings. Vulnerable Child Youth Stud. 2019;14(2):181–190. doi:10.1080/17450128.2019.1576960